I believe it will be from Sinopharm as they had already submitted for registration with China Health regulators. It cannot be Pfizer as their meeting with FDA is on 10/12 and details cannot be revealed until then. Astrazeneca is going trough retrial. Cansino is due only in 2022. Sinovac a bit quiet on their registration. -----------------------------------------------------------------------------------------------------------------------------------
KUALA LUMPUR: The Health Ministry is expected to receive data on phase three of the Covid-19 vaccine clinical trial from one of 10 companies it is negotiating with.
Health director-general Tan Sri Dr Noor Hisham Abdullah said the report "will most likely" be ready next week, but stressed that the vaccine will only get a green light if the company is able to acquire a licence.
"After receiving (the report), we will study it. (Later), the vaccine will be brought to the National Pharmaceutical Regulatory Agency (NPRA) and the Food and Drug Administration (FDA) for their approvals.
"If the vaccine is neither approved nor licensed, it means it can't be sold like other medicines in the country.
Sinopharm had indicated earlier that they will only release its clinical trial data only after approval from Chinese Health authorities. If Noor Hisham's news is used as basis, that means approval of Sinopharm is imminent next week. I hope I am right.
Flush out the short term and contra player to make kanger price more stable. Easier rot invester to average the price n take more profit next year, smile
Kanger International Bhd (0170) • KANGER dropped 2.7% or 0.5 sen to RM0.18 yesterday. • Chart-wise, share price has been in consolidation mode for some time with trading volume improving of late showing signs of stealth buying pattern. News of the company signing collaboration agreement Sinopharm to distribute Covid-19 vaccine and has received support from Ministry of Science, Technology and Innovation is likely to spur buying interest as one of the potential vaccine-play stocks. • From here, resistance levels are expected at RM0.195 (R1) and RM0.230 (R2) level. • On the downside, support levels are set at RM0.160 (S1) and RM0.120 (S2).
with all the good news from NPRA1985 & others... this Kura2 still no move.. for those who willing to wait and hold on..I wish u all the best.. for those who sakit hati.. just ignore this Kura2 and go invest in some other better stocks.
purchase kanger not because of 1 QR but future prospect and growth. The bamboo business looks bright and if everything goes well with the vaccine distribution then will be an additional bonus that will carry kanger to next level...
The future prospect of kanger is definitely bright. Cant blame the bad QR report due to the pandemic affecting the businesss. Now that China's economy is back to normal, Kanger will be back on track to making profit from its core business (especially with the commencement of operations of the new high tech bamboo processing plant) and its diversification into various sectors including healthcare.
Hl123456 purchase kanger not because of 1 QR but future prospect and growth. The bamboo business looks bright and if everything goes well with the vaccine distribution then will be an additional bonus that will carry kanger to next level... 01/12/2020 10:00 AM
------------------------------------------
Exactly
Those who sell down today doesnt even know what they are investing..they only follow the hype of vaccine
NPRA1985 The future prospect of kanger is definitely bright. Cant blame the bad QR report due to the pandemic affecting the businesss. Now that China's economy is back to normal, Kanger will be back on track to making profit from its core business (especially with the commencement of operations of the new high tech bamboo processing plant) and its diversification into various sectors including healthcare. 01/12/2020 10:04 AM
@bowman Pharmaniaga needs to plan because they will be distributing a vaccine that requires -70C ie Pfizer vaccine. This has never been done in the history of Malaysia or even worldwide. Zuellig pharma will be distributing on behalf of Kanger and they have vast experience distributing vaccines that require storage at 2-8 C. Sinopharm vaccine only requires storage at 2-8C. Hence, its as easy as ABC for Zuellig Pharma. Please use some brain cells to think lolol Dont just act like zombie lol
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
greenland
378 posts
Posted by greenland > 2020-12-01 06:38 | Report Abuse
Fully agree Noobie